SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001354488-15-000419
Filing Date
2015-02-02
Accepted
2015-02-02 16:22:52
Documents
3
Period of Report
2015-01-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tbuff_8k.htm 8-K 32534
2 EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN THE COMPANY AND ROB HARRIS tbuff_ex101.htm EX-10.1 226078
3 EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN THE COMPANY AND SCOTT LANGILLE tbuff_ex102.htm EX-10.2 226596
  Complete submission text file 0001354488-15-000419.txt   486604
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31198 | Film No.: 15567215
SIC: 2834 Pharmaceutical Preparations